An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
menstruating females at least 18 years of age
BMI less than 30
moderate to severe breast pain associated with the menstrual cycle
in good general health
pregnant within the last 6 months
has taken in the last 3 months or currently taking hormonal contraception
history of malignancy or currently being treated for cancer of the breast or genital organs
has had breast implants or breast reduction surgery